Finance

Lists
AWY0:FRA
Percheron Therapeutics Ltd
€0,00050
0,00%
(0,00) 1D
30 Sep., 08:04:53 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for AWY0...
Open
€0,00
High
€0,00
Low
€0,00
Mkt. cap
4,56Ā m
Volume
0,00
52-wk high
€0,00
52-wk low
€0,00
No. of employees
8
Open
€0,00
High
€0,00
Low
€0,00
Mkt. cap
4,56Ā m
Volume
0,00
52-wk high
€0,00
52-wk low
€0,00
No. of employees
8
About Percheron Therapeutics Ltd
CEOJames Garner
Employees8
Founded2000
HeadquartersToorak, Victoria, Australiƫ
SectorPharmaceutical industry
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
44,20Ā k
44,20Ā k
377,60Ā k
377,60Ā k
Cost of goods sold
58,63Ā k
58,63Ā k
31,06Ā k
31,06Ā k
Cost of revenue
58,63Ā k
58,63Ā k
31,06Ā k
31,06Ā k
Research and development expenses
671,18Ā k
671,18Ā k
372,60Ā k
372,60Ā k
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
732,56Ā k
732,56Ā k
657,51Ā k
657,51Ā k
Operating expense
1,53Ā m
1,53Ā m
1,19Ā m
1,19Ā m
Total operating expenses
1,59Ā m
1,59Ā m
1,22Ā m
1,22Ā m
Operating income
-1,55Ā m
-1,55Ā m
-840,64Ā k
-840,64Ā k
Other non operating income
-
-
-
-
EBT including unusual items
-1,55Ā m
-1,55Ā m
-843,02Ā k
-843,02Ā k
EBT excluding unusual items
-1,55Ā m
-1,55Ā m
-843,02Ā k
-843,02Ā k
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1,55Ā m
-1,55Ā m
-843,02Ā k
-843,02Ā k
Net profit margin
-3Ā 512,84%
-3Ā 512,84%
-223,26%
-223,26%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-5,29Ā k
-5,29Ā k
-2,38Ā k
-2,38Ā k
Net interest expenses
-5,29Ā k
-5,29Ā k
-2,38Ā k
-2,38Ā k
Depreciation and amortization charges
9,56Ā k
9,56Ā k
100,22Ā k
100,22Ā k
EBITDA
-1,54Ā m
-1,54Ā m
-740,42Ā k
-740,42Ā k
Gain or loss from assets sale
-
-
20,00
20,00
AI content may include mistakes. Learn more
Google-programme